Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Hemant Roy
Northwestern University, Department: Biomedical Engineering
Should you be removed from our database? Contact us at [email protected]. Read more below.
NanoCytomics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Roy holds equity in startup companies that hold licenses to intellectual property being developed in the research and stand to benefit financially from the commercialization of those products.
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology
Prostate cancer is the leading cancer among U.S. men. The biggest limitation of current prostate cancer management that it is essentially impossible to accurately prognosticate which patients harbor aggressive cancers that progress into a metastatic disease and need treatment and which patients have non-aggressive indolent cancers that would not pose harm. Technology developed in the proposed project will address this issue by detecting alterations in nanoscale morphology of prostate epithelial cells that are highly predictive of the risk of progression.
Filed on October 22, 2015.
Tell us what you know about Hemant Roy's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Hemant Roy filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Hemant Roy | Boston Medical Center | Conflict of Interest | American BioOptics | $0 - $4,999 |
| Hemant K. Roy | Northwestern University | Conflict of Interest | American BioOptics | $0 - $4,999 |
| Hemant Roy | Boston Medical Center | Conflict of Interest | NanoCytomics | Value cannot be readily determined |
| Hemant Roy | Boston Medical Center | Conflict of Interest | NanoCytomics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.